2021
DOI: 10.1016/j.parkreldis.2021.07.022
|View full text |Cite
|
Sign up to set email alerts
|

Mild cognitive impairment and abnormal brain metabolic expression in idiopathic REM sleep behavior disorder

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
18
0
1

Year Published

2022
2022
2023
2023

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(19 citation statements)
references
References 30 publications
0
18
0
1
Order By: Relevance
“… 39 Recently, our group reported that dnPDRBD-RP predicted cognitive decline in patients with iRBD. 5 The dnPDRBD-RP showed a relative metabolic decrease in the parietal and occipital cortex and precuneus, highlighting the importance of hypometabolism in posterior brain regions predicting disease progression in patients with iRBD. On the other hand, although MCI and MPS have been suggested as important predictive markers for phenoconversion to PD/DLB in patients with iRBD, 40 neither of them significantly associated with higher phenoconversion rate in the current study.…”
Section: Discussionmentioning
confidence: 95%
See 3 more Smart Citations
“… 39 Recently, our group reported that dnPDRBD-RP predicted cognitive decline in patients with iRBD. 5 The dnPDRBD-RP showed a relative metabolic decrease in the parietal and occipital cortex and precuneus, highlighting the importance of hypometabolism in posterior brain regions predicting disease progression in patients with iRBD. On the other hand, although MCI and MPS have been suggested as important predictive markers for phenoconversion to PD/DLB in patients with iRBD, 40 neither of them significantly associated with higher phenoconversion rate in the current study.…”
Section: Discussionmentioning
confidence: 95%
“…2 Similarly, in a previous study of our cohort of patients with iRBD, we found a phenoconversion rate of 27.3% to PD, DLB, or MSA at a mean follow-up of 3 years, and the phenoconversion rate estimated using the Kaplan-Meier method was 35.5% at 5 years. 3 Studies on cognition in patients with iRBD identified impairments in multiple cognitive domains, such as attention, executive function, episodic memory, and visuospatial abilities, 4,5 and a high prevalence of mild cognitive impairment (MCI), from 32% to 50%. 6,7 Moreover, long-term follow-up studies found that >90% of patients with RBD who later developed DLB had MCI at baseline.…”
mentioning
confidence: 99%
See 2 more Smart Citations
“…48,49 Another cohort found insula volume was decreased in both MCI-LB and MCI-AD compared with controls, but found no significant difference between MCI-AD and MCI-LB in a region of interest analysis and no difference between the groups in the insula using a voxel-wise analysis. 47 Low occipital uptake on metabolism/perfusion imaging: MCI-LB patients have consistently demonstrated reduced fluorodeoxyglucose (FDG) PET uptake in posterior brain areas 15,17,[51][52][53][54] One recent study found that visual rating of FDG PET demonstrated an accuracy of 77% to differentiate MCI-LB from MCI-AD, 52 whereas another found that 50% of MCI-LB had primary visual cortex hypometabolism, compared with 24% of MCI-AD. 17 Another study found that using the cingulate:cuneus/precuneus ratio demonstrated sensitivity of 59% and specificity of 90% to differentiate MCI-LB from MCI-AD.…”
Section: Potential Biomarkers (Table 4)mentioning
confidence: 99%